Coriell Institute for Medical Research
Coriell Institute of Medical Research
  • Request a Quote
  • Donate
  • Login
  • View Cart
Sample Catalog | Custom Services | Core Facilities | Genomic Data Search
  • Biobank
    • NIGMS
    • NINDS
    • NIA
    • NHGRI
    • NEI
    • Allen Cell Collection
    • Rett Syndrome iPSC Collection
    • Autism Research Resource
    • HD Community Biorepository
    • CDC Cell and DNA
    • J. Craig Venter Institute
    • Orphan Disease Center Collection
    • All Biobanks
  • Research
    • Overview
    • Meet Our Scientists
      • Our Faculty
      • Our Scientific Staff
    • Camden Cancer Research Center
    • Epigenetic Therapies SPORE
    • Core Facilities
    • Epigenomics
    • Camden Opioid Research Initiative (CORI)
    • The Issa & Jelinek Lab
    • The Jian Huang Lab
    • The Luke Chen Lab
      • The Lab
      • The Team
      • Publications
    • The Scheinfeldt Lab
    • The Shumei Song Lab
    • The Nora Engel Lab
      • The Lab
      • The Team
      • Publications
    • Publications
  • Services
    • Overview
    • Biobanking Services
      • Core Services
      • Project Management
      • Research Support Services
      • Sample Cataloging
      • Sample Collection Kits
      • Sample Data Management
      • Sample Distribution
      • Sample Management
      • Sample Procurement
      • Sample Storage
    • Bioinformatics and Biostatistics Services
    • Cellular and Molecular Services
      • Biomarker Research Solutions
      • Cell Culture
      • Nucleic Acid Isolation and Quality Control
    • Clinical Trial Support
      • Overview
      • Sample Collection
      • Data Management
      • Sample Processing and QC
      • Storage and Distribution
      • Biomarker Services
      • Data Analaysis
    • Core Facilties
      • Overview
      • Animal and Xenograft
      • Bioinformatics and Biostatistics
      • Cell Imaging
      • CRISPR Gene Engineering
      • Flow Cytometry and Cell Sorting
      • Genomics and Epigenomics
      • iPSC - Induced Pluripotent Stem Cells
      • Organoids
    • Coriell Marketplace
    • Genomic, Epigenomic and Multiomics Services
    • Stem Cells and iPSC Services
      • Core Services
      • Reprogramming
      • Characterization and Quality Control
      • Differentiated Cell Lines
      • iPSC-Derived Organoids
      • iPSC Expansion
      • iPSC Gene Editing
  • Ordering
    • Stem Cells
    • Cell Lines
    • DNA and RNA
    • Featured Products
      • FFPE
      • HMW DNA
    • Genomic Data Search
    • Search by Catalog ID
    • Help
      • Create Account
      • Order Online
      • Ordering FAQ
      • FAQs/Culture Instructions
      • Reference Materials
        • Biobanks
        • NIGMS Repository
        • NHGRI Repository
        • NINDS Repository
        • NIA Repository
        • NIST
        • GeT-RM
      • Secondary Distribution Policies
      • MTA Assurance Form
      • Shipment Policy
      • Contact Customer Service
  • About Us
    • Our History
    • Meet Our Team
    • Meet Our Board
    • Education
      • Science Fair
      • Summer Experience
      • Outreach
      • Research Program Internship
    • Press Room
      • Press Releases
      • Coriell Blog
      • Annual Report
    • Careers
      • Working at Coriell
    • Giving
      • Donate
      • Giving FAQ
    • Contact Us
    • Legal Notice
  • Login View Cart
search submit
  • Enzyme

Enzyme

GLB
https://enzyme.expasy.org/EC/3.2.1.23

Catalog IDDescriptionPercent Normal ActivitySpecimen AssayedRemark
GM00918GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I<1 According to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM01602MUCOPOLYSACCHARIDOSIS TYPE IVB<7fibroblastsGiugliani et al (Clin Genet 32:313-325 1987) assayed B-galactosidase activity in this fibroblast culture using 4-methylumbelliferyl B-Dgalactoside and with the alternative artificial substrates: 4MU B-Dfucoside and 4MU A-L-arabinoside. Deficient enzyme activity towards all of these substrates was observed. The respective observed values were 7.2% 2.6% and 1.2% of normal control activities. Oshima et al (Am J Hum Genet 49:1091-1093 1991) reported that DNA from this Morquio B disease patient had 2 mutations in the B-galactosidase gene: Trp-273>Leu and Arg-482>His.
GM01602MUCOPOLYSACCHARIDOSIS TYPE IVB4 According to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM02439GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II, OR JUVENILE TYPE  According to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM03251MUCOPOLYSACCHARIDOSIS TYPE IVB<6fibroblastsGiugliani et al (Clin Genet 32:313-325 1987) assayed B-galactosidase activity in this fibroblast culture using 4-methylumbelliferyl B-Dgalactoside and with the alternative artificial substrates: 4MU B-Dfucoside and 4MU A-L-arabinoside. Deficient enzyme activity towards all of these substrates was observed. The respective observed values were 6.4% 2.2% and .7% of normal control activities. Oshima et al (Am J Hum Genet 49:1091-1093 1991) reported that DNA from this Morquio B disease patient had 2 mutations in the B-galactosidase gene: Trp-273>Leu and Trp-509>Cys.
GM03251MUCOPOLYSACCHARIDOSIS TYPE IVB4 According to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM03589GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I<1 According to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM05335GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I1-2fibroblasts/WBCsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM10919GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I<1fibroblastsAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM11473CANINE GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1 umbilical cordAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM11474CANINE GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1 umbilical cordAccording to the submitter, biochemical test results for this subject showed decreased enzyme activity.
GM21262GALACTOSIALIDOSIS; GSL<20leukocytesAccording to the submitter biochemical test results for this subject showed decreased enzyme activity.

Our mission is to prevent and cure disease through biomedical research.

CONTACT US

CUSTOMER SERVICE
customerservice@coriell.org (800) 752-3805 • (856) 757-4848
Subscribe to our newsletter here

Coriell Institute for Medical Research
403 Haddon Avenue Camden, NJ 08103, USA (856) 966-7377

Ⓒ 2025 Coriell Institute. All rights reserved.

  • Facebook
  • Linkedin
  • Youtube